La chaîne d'options affiche les données clés des options sur actions de Maxeon Solar Technologies à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Maxeon Solar Technologies..

Maxeon Solar Technologies (NASDAQ:MAXN) Stock, Chaîne d'Options

Maxeon Solar Technologies

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.

Maxeon Solar Technologies, Ltd. - Ordinary Shares

Maxeon Solar Technologies Ltd

WIIM

Principal Financial Group shares are trading lower following a Q1 adjusted EPS miss.

Willis Towers Watson shares are trading lower on continued weakness after the company reported worse-than-expected Q1 financial results on Thursday.

Bernstein analyst Mark Shmulik maintains Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Market Perform and raises the price target from $165 to $185.

News

Price Target

Analyst Ratings

GOOGL

Bernstein Maintains Market Perform on Alphabet, Raises Price Target to $185

Citigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>) with a Neutral and lowers the price target from $11 to $8.75.

TDOC

Citigroup Maintains Neutral on Teladoc Health, Lowers Price Target to $8.75

<a href="https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-april-2025" title="https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-april-2025">https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-april-2025</a>

Biotech

General

BHVN

'Biohaven Withdraws Initial Marketing Authorization Application For Dazluma' - European Medical Agency

Centene shares are trading lower after the company issued FY25 EPS guidance below estimates.

CHACU

Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

PHOE

Citigroup analyst Daniel Grosslight maintains Hims &amp; Hers Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) with a Sell and lowers the price target from $27 to $25.

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Citigroup Maintains Sell on Hims & Hers Health, Lowers Price Target to $25

VRSN

VeriSign shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 sales guidance above estimates.

CHTR

Charter Communications shares are trading higher after the company reported better-than-expected Q1 sales results.

Citigroup analyst Adam Spielman maintains Altria Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) with a Neutral and raises the price target from $52 to $55.

Citigroup Maintains Neutral on Altria Group, Raises Price Target to $55

Encompass Health shares are trading higher after Barclays raised its price target on the stock from $118 to $129.

ERIE

Erie Indemnity shares are trading lower after the company reported Q1 financial results and missed its EPS estimate.

KNSL

Kinsale Capital Group shares are trading lower after the company reported a Q1 revenue miss.

Insmed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NASDAQ">INSM</a>) has outperformed the market over the past 10 years by 3.02% on an annualized basis producing an average annual return of 13.16%. Currently, Insmed has a market capitalization of $12.29 billion. 
Buying $1000 In INSM: If an investor had bought $1000 of INSM stock 10 years ago, it would be worth $3,284.86 today based on a price of $67.90 for INSM at the time of writing.
<h3>Insmed's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745591414_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

INSM

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

UnitedHealth Group shares are trading lower after Barclays cut its price target on the stock from $560 to $513.

Citigroup analyst Ronald Josey maintains Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Buy and raises the price target from $195 to $200.

GOOG

Citigroup Maintains Buy on Alphabet, Raises Price Target to $200

GameStop Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) is back in the spotlight, and this time, it's not just <a href="https://www.benzinga.com/topic/meme-stocks">about stock memes</a> — it's about real action.
With Nintendo Switch 2 preorders live, GameStop offers up to $175 off when you trade in your older model, <a href="https://mashable.com/article/nintendo-switch-trade-in-deal-gamestop-switch-2-preorder">reported</a> Mashable, and it's creating a stir. GameStop's trade-in deals might be too good to pass up if you&#8217;re considering upgrading your console.
The Switch 2, priced at $449.99 for the standard edition, is generating significant buzz, and GameStop is positioning itself as the go-to retailer with the most generous trade-in credits. They&#8217;re even offering Pro members an extra 10% in store credit, making it an even sweeter deal.
Read Also: <a href="https://www.benzinga.com/news/25/04/44984453/gamestop-stock-rises-amid-switch-2-preorders-whats-going-on">GameStop Stock Rises Amid Switch 2 Preorders: What&#8217;s Going On?</a>
But what about the stock?
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0425"><img loading="lazy" decoding="async" width="627" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25091552/Screenshot-2025-04-25-at-6.45.38-PM.png" alt="" class="wp-image-888819" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25091552/Screenshot-2025-04-25-at-6.45.38-PM.png 627w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/25091552/Screenshot-2025-04-25-at-6.45.38-PM-300x234.png 300w" sizes="(max-width: 627px) 100vw, 627px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0425">Chart created using Benzinga Pro</a>
While GameStop stock has slipped by -11.68% year-to-date, there's reason to believe the stock might be gearing up for a rebound. Trading at $27.08, the stock is above its five-day, 20-day and 50-day exponential moving averages, signaling strong bullish momentum. 
GameStop stock is also trading higher than its eight-day, 20-day, and 50-day simple moving averages, all indicating bullish signals. The MACD (moving average convergence/divergence) indicator is positive at 0.83, supporting the bullish momentum and the RSI (relative strength index) is at 57.90, neither overbought nor oversold. 
Overall, GameStop&#8217;s stock chart is suggesting there&#8217;s more room for growth, despite some slight selling pressure.
For investors, GameStop is sending mixed signals — its stock has dipped this year, but the bullish trends and gaming retail momentum provide hope. With Switch 2 preorders ramping up, this might just be the perfect time to add GameStop stock to your watchlist.
GameStop might just be on the path to a new game plan &#8211; and investors could be in for a winning round.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44990522/nintendo-stock-hits-all-time-high-amid-switch-2-preorder-frenzy-what-you-need-to-know">Nintendo Stock Hits All-Time High Amid Switch 2 Preorder Frenzy: What You Need To Know</a></li>
</ul>
Image: Shutterstock

Gaming

Technicals

GameStop Stock Gets Nintendo Switch 2 Boost: But Should Investors Hit Buy?

Alliance Global Partners analyst Gaurav Mehta initiates coverage on Sky Harbour Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKYH#NYSE">SKYH</a>) with a Buy rating and announces Price Target of $14.5.

Initiation

SKYH

Alliance Global Partners Initiates Coverage On Sky Harbour Group with Buy Rating, Announces Price Target of $14.5

Commodities

Stock Split

Press Releases

Maxeon Receives Nasdaq Notification and is Proceeding with Approved Reverse Stock Split

Pomerantz Law Firm Announces the Filing of a Class Action Against Maxeon Solar Technologies, Ltd. - MAXN

Maxeon Announces CEO Leadership Transition

Maxeon Provides Update on CBP Detention of its Solar Panels

Maxeon Announces Restructuring of Business Portfolio

Earnings

Maxeon Solar Technologies Announces Third Quarter 2024 Financial Results

Maxeon and Tongwei Solar Announce Settlement Agreement Resolving Patent Infringement Lawsuit

Maxeon Provides Strategic Business Update

MAXN

Ascent Solar Technologies, Inc - Common Stock

Ascent Solar Technologies

Datavault AI

GCT Semiconductor Holding, Inc. Common Stock

GCT Semiconductor Hldgs

GSI Technology

Intchains Group Limited - American Depositary Shares

Intchains Gr

Kopin

SemiLEDs

Mobix Labs

Everspin Technologies, Inc. - Common Stock

Everspin Technologies

Magnachip Semiconductor Corporation Common Stock

MagnaChip Semiconductor

Nano Labs

Peraso

Pixelworks

QuickLogic

Semilux International Ltd. - Ordinary Shares

Semilux International

SmartKem

Sequans Communications S.A. American Depositary Shares (each representing ten (10) Ordinary Shares)

Comments

Maxeon Solar Technologies

Maxeon Solar Technologies (MAXN) Options

Maxeon Solar Technologies (NASDAQ:MAXN) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL